Somatostatin Receptor Type 2 Market, Global Outlook and Forecast 2022-2028

Somatostatin Receptor Type 2 Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281508 | No. of Pages: 66 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022
This report contains market size and forecasts of Somatostatin Receptor Type 2 in Global, including the following market information:
Global Somatostatin Receptor Type 2 Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Somatostatin Receptor Type 2 market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
CRN-00808 Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Somatostatin Receptor Type 2 include Amryt Pharma plc, Crinetics Pharmaceuticals Inc, Daewoong Pharmaceutical Co Ltd, Ipsen SA, Progenics Pharmaceuticals Inc, Strongbridge Biopharma plc and Zucara Therapeutics Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Somatostatin Receptor Type 2 companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Somatostatin Receptor Type 2 Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Somatostatin Receptor Type 2 Market Segment Percentages, by Type, 2021 (%)
    CRN-00808
    Lanreotide Acetate
    PRL-2903
    Others
Global Somatostatin Receptor Type 2 Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Somatostatin Receptor Type 2 Market Segment Percentages, by Application, 2021 (%)
    Hormonal Disorder
    Oncology
    Metabolic Disorder
    Others
Global Somatostatin Receptor Type 2 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Somatostatin Receptor Type 2 Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Somatostatin Receptor Type 2 revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Somatostatin Receptor Type 2 revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Amryt Pharma plc
    Crinetics Pharmaceuticals Inc
    Daewoong Pharmaceutical Co Ltd
    Ipsen SA
    Progenics Pharmaceuticals Inc
    Strongbridge Biopharma plc
    Zucara Therapeutics Inc
1 Introduction to Research & Analysis Reports
    1.1 Somatostatin Receptor Type 2 Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Somatostatin Receptor Type 2 Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Somatostatin Receptor Type 2 Overall Market Size
    2.1 Global Somatostatin Receptor Type 2 Market Size: 2021 VS 2028
    2.2 Global Somatostatin Receptor Type 2 Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Somatostatin Receptor Type 2 Players in Global Market
    3.2 Top Global Somatostatin Receptor Type 2 Companies Ranked by Revenue
    3.3 Global Somatostatin Receptor Type 2 Revenue by Companies
    3.4 Top 3 and Top 5 Somatostatin Receptor Type 2 Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Somatostatin Receptor Type 2 Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Somatostatin Receptor Type 2 Players in Global Market
        3.6.1 List of Global Tier 1 Somatostatin Receptor Type 2 Companies
        3.6.2 List of Global Tier 2 and Tier 3 Somatostatin Receptor Type 2 Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Somatostatin Receptor Type 2 Market Size Markets, 2021 & 2028
        4.1.2 CRN-00808
        4.1.3 Lanreotide Acetate
        4.1.4 PRL-2903
        4.1.5 Others
    4.2 By Type - Global Somatostatin Receptor Type 2 Revenue & Forecasts
        4.2.1 By Type - Global Somatostatin Receptor Type 2 Revenue, 2017-2022
        4.2.2 By Type - Global Somatostatin Receptor Type 2 Revenue, 2023-2028
        4.2.3 By Type - Global Somatostatin Receptor Type 2 Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Somatostatin Receptor Type 2 Market Size, 2021 & 2028
        5.1.2 Hormonal Disorder
        5.1.3 Oncology
        5.1.4 Metabolic Disorder
        5.1.5 Others
    5.2 By Application - Global Somatostatin Receptor Type 2 Revenue & Forecasts
        5.2.1 By Application - Global Somatostatin Receptor Type 2 Revenue, 2017-2022
        5.2.2 By Application - Global Somatostatin Receptor Type 2 Revenue, 2023-2028
        5.2.3 By Application - Global Somatostatin Receptor Type 2 Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Somatostatin Receptor Type 2 Market Size, 2021 & 2028
    6.2 By Region - Global Somatostatin Receptor Type 2 Revenue & Forecasts
        6.2.1 By Region - Global Somatostatin Receptor Type 2 Revenue, 2017-2022
        6.2.2 By Region - Global Somatostatin Receptor Type 2 Revenue, 2023-2028
        6.2.3 By Region - Global Somatostatin Receptor Type 2 Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Somatostatin Receptor Type 2 Revenue, 2017-2028
        6.3.2 US Somatostatin Receptor Type 2 Market Size, 2017-2028
        6.3.3 Canada Somatostatin Receptor Type 2 Market Size, 2017-2028
        6.3.4 Mexico Somatostatin Receptor Type 2 Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Somatostatin Receptor Type 2 Revenue, 2017-2028
        6.4.2 Germany Somatostatin Receptor Type 2 Market Size, 2017-2028
        6.4.3 France Somatostatin Receptor Type 2 Market Size, 2017-2028
        6.4.4 U.K. Somatostatin Receptor Type 2 Market Size, 2017-2028
        6.4.5 Italy Somatostatin Receptor Type 2 Market Size, 2017-2028
        6.4.6 Russia Somatostatin Receptor Type 2 Market Size, 2017-2028
        6.4.7 Nordic Countries Somatostatin Receptor Type 2 Market Size, 2017-2028
        6.4.8 Benelux Somatostatin Receptor Type 2 Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Somatostatin Receptor Type 2 Revenue, 2017-2028
        6.5.2 China Somatostatin Receptor Type 2 Market Size, 2017-2028
        6.5.3 Japan Somatostatin Receptor Type 2 Market Size, 2017-2028
        6.5.4 South Korea Somatostatin Receptor Type 2 Market Size, 2017-2028
        6.5.5 Southeast Asia Somatostatin Receptor Type 2 Market Size, 2017-2028
        6.5.6 India Somatostatin Receptor Type 2 Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Somatostatin Receptor Type 2 Revenue, 2017-2028
        6.6.2 Brazil Somatostatin Receptor Type 2 Market Size, 2017-2028
        6.6.3 Argentina Somatostatin Receptor Type 2 Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Somatostatin Receptor Type 2 Revenue, 2017-2028
        6.7.2 Turkey Somatostatin Receptor Type 2 Market Size, 2017-2028
        6.7.3 Israel Somatostatin Receptor Type 2 Market Size, 2017-2028
        6.7.4 Saudi Arabia Somatostatin Receptor Type 2 Market Size, 2017-2028
        6.7.5 UAE Somatostatin Receptor Type 2 Market Size, 2017-2028
7 Players Profiles
    7.1 Amryt Pharma plc
        7.1.1 Amryt Pharma plc Corporate Summary
        7.1.2 Amryt Pharma plc Business Overview
        7.1.3 Amryt Pharma plc Somatostatin Receptor Type 2 Major Product Offerings
        7.1.4 Amryt Pharma plc Somatostatin Receptor Type 2 Revenue in Global Market (2017-2022)
        7.1.5 Amryt Pharma plc Key News
    7.2 Crinetics Pharmaceuticals Inc
        7.2.1 Crinetics Pharmaceuticals Inc Corporate Summary
        7.2.2 Crinetics Pharmaceuticals Inc Business Overview
        7.2.3 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Major Product Offerings
        7.2.4 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Revenue in Global Market (2017-2022)
        7.2.5 Crinetics Pharmaceuticals Inc Key News
    7.3 Daewoong Pharmaceutical Co Ltd
        7.3.1 Daewoong Pharmaceutical Co Ltd Corporate Summary
        7.3.2 Daewoong Pharmaceutical Co Ltd Business Overview
        7.3.3 Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Major Product Offerings
        7.3.4 Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Revenue in Global Market (2017-2022)
        7.3.5 Daewoong Pharmaceutical Co Ltd Key News
    7.4 Ipsen SA
        7.4.1 Ipsen SA Corporate Summary
        7.4.2 Ipsen SA Business Overview
        7.4.3 Ipsen SA Somatostatin Receptor Type 2 Major Product Offerings
        7.4.4 Ipsen SA Somatostatin Receptor Type 2 Revenue in Global Market (2017-2022)
        7.4.5 Ipsen SA Key News
    7.5 Progenics Pharmaceuticals Inc
        7.5.1 Progenics Pharmaceuticals Inc Corporate Summary
        7.5.2 Progenics Pharmaceuticals Inc Business Overview
        7.5.3 Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Major Product Offerings
        7.5.4 Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Revenue in Global Market (2017-2022)
        7.5.5 Progenics Pharmaceuticals Inc Key News
    7.6 Strongbridge Biopharma plc
        7.6.1 Strongbridge Biopharma plc Corporate Summary
        7.6.2 Strongbridge Biopharma plc Business Overview
        7.6.3 Strongbridge Biopharma plc Somatostatin Receptor Type 2 Major Product Offerings
        7.6.4 Strongbridge Biopharma plc Somatostatin Receptor Type 2 Revenue in Global Market (2017-2022)
        7.6.5 Strongbridge Biopharma plc Key News
    7.7 Zucara Therapeutics Inc
        7.7.1 Zucara Therapeutics Inc Corporate Summary
        7.7.2 Zucara Therapeutics Inc Business Overview
        7.7.3 Zucara Therapeutics Inc Somatostatin Receptor Type 2 Major Product Offerings
        7.7.4 Zucara Therapeutics Inc Somatostatin Receptor Type 2 Revenue in Global Market (2017-2022)
        7.7.5 Zucara Therapeutics Inc Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com